Literature DB >> 26301081

Agomelatine and migraine management: a successfully treated case series.

Beatriz O Plasencia-García1, Samuel L Romero-Guillena2, Alicia Quirós-López3, Sergio Ruiz-Doblado3.   

Abstract

Entities:  

Year:  2015        PMID： 26301081      PMCID： PMC4535043          DOI： 10.1177/2045125315584869

Source DB:  PubMed          Journal:  Ther Adv Psychopharmacol        ISSN： 2045-1253


× No keyword cloud information.
  8 in total

1.  The International Classification of Headache Disorders: 2nd edition.

Authors: 
Journal:  Cephalalgia       Date:  2004       Impact factor: 6.292

2.  New appendix criteria open for a broader concept of chronic migraine.

Authors:  J Olesen; M-G Bousser; H-C Diener; D Dodick; M First; P J Goadsby; H Göbel; M J A Lainez; J W Lance; R B Lipton; G Nappi; F Sakai; J Schoenen; S D Silberstein; T J Steiner
Journal:  Cephalalgia       Date:  2006-06       Impact factor: 6.292

Review 3.  Topiramate for the prophylaxis of episodic migraine in adults.

Authors:  Mattias Linde; Wim M Mulleners; Edward P Chronicle; Douglas C McCrory
Journal:  Cochrane Database Syst Rev       Date:  2013-06-24

Review 4.  Potential therapeutic use of melatonin in migraine and other headache disorders.

Authors:  Mario F P Peres; Marcelo R Masruha; Eliova Zukerman; Carlos Alberto Moreira-Filho; Esper A Cavalheiro
Journal:  Expert Opin Investig Drugs       Date:  2006-04       Impact factor: 6.206

5.  [Possibilities of preventive treatment of migraine with the MT1- and MT2 agonist and 5-HT2с receptor antagonist agomelatin (valdoxan)].

Authors:  G R Tabeeva; A V Sergeev; S A Gromova
Journal:  Zh Nevrol Psikhiatr Im S S Korsakova       Date:  2011

6.  The role of melatonin in anaesthesia and critical care.

Authors:  Madhuri S Kurdi; Tushar Patel
Journal:  Indian J Anaesth       Date:  2013-03

Review 7.  A possible new option for migraine management: agomelatine.

Authors:  Riccardo Guglielmo; Giovanni Martinotti; Massimo Di Giannantonio; Luigi Janiri
Journal:  Clin Neuropharmacol       Date:  2013 Mar-Apr       Impact factor: 1.592

Review 8.  Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies.

Authors:  David Taylor; Anna Sparshatt; Seema Varma; Olubanke Olofinjana
Journal:  BMJ       Date:  2014-03-19
  8 in total
  4 in total

1.  Agomelatine Exerts an Anti-inflammatory Effect by Inhibiting Microglial Activation Through TLR4/NLRP3 Pathway in pMCAO Rats.

Authors:  Wijitra Chumboatong; Satchakorn Khamchai; Chainarong Tocharus; Piyarat Govitrapong; Jiraporn Tocharus
Journal:  Neurotox Res       Date:  2021-11-29       Impact factor: 3.911

2.  α2- and β2-Adrenoreceptor-Mediated Efficacy of the Atypical Antidepressant Agomelatine Combined With Gabapentin to Suppress Allodynia in Neuropathic Rats With Ligated Infraorbital or Sciatic Nerve.

Authors:  Saïd M'Dahoma; Matthieu Poitevin; Eric Dabala; Hugo Payan; Cecilia Gabriel; Elisabeth Mocaër; Sylvie Bourgoin; Michel Hamon
Journal:  Front Pharmacol       Date:  2018-06-07       Impact factor: 5.810

3.  Therapeutic role of melatonin in migraine prophylaxis: A systematic review.

Authors:  Rujin Long; Yousheng Zhu; Shusheng Zhou
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817

Review 4.  Nutrients to Improve Mitochondrial Function to Reduce Brain Energy Deficit and Oxidative Stress in Migraine.

Authors:  Michal Fila; Cezary Chojnacki; Jan Chojnacki; Janusz Blasiak
Journal:  Nutrients       Date:  2021-12-10       Impact factor: 5.717
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.